FDA Inspection 1041358 — Amgen Europe BV
The FDA completed an inspection of Amgen Europe BV on January 11, 2018 in Breda. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 11, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Breda (Netherlands)